14158 Results (Page 104 of 567)
All Market Research Reports
Romania ECG Equipments Market Analysis
Romania's ECG Equipment Market is expected to grow from $26 Mn in 2022 to $46 Mn in 2030 with a CAGR of 7.55% for the forecasted year 2022-30. Heart disease is more prevalent as people age in Romania, which has an aging population. The need for healthcare providers to better diagnose and treat cardiac disease in elderly individuals is anticipated to increase demand for ECG equipment. The market is segmented by product type and by end user. Some key players in this market include BioSintex, PRION POCT, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Romania Contraceptive Devices Market Analysis
Romania's Contraceptive Devices Market is expected to witness growth from $37 Mn in 2022 to $71 Mn in 2030 with a CAGR of 8.25% for the forecasted year 2022-30. In Romania, there is a rising acceptance of family planning and contraception, which has increased the demand for contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Italtrade & Co S.R.L, Adar Unic Solutions SRL, Organon Heist, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Romania Dialysis Market Analysis
This report presents a strategic analysis of the Romania Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Romania Dialysis Market, offering unmatched value, accuracy, and expert insights.
Romania Diabetes Drugs Market Analysis
This report presents a strategic analysis of the Romania Diabetes Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Romania Diabetes Drugs Market, offering unmatched value, accuracy and expert insights.
Romania Clinical Diagnostics Market Analysis
This report presents a strategic analysis of the Romania Clinical Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Romania Clinical Diagnostics Market, offering unmatched value, accuracy and expert insights.
Romania Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Romania Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Romania Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Brazil Alzheimer’s Therapeutics Market Analysis
Brazil Alzheimer’s Therapeutics Market was valued at $120 Mn in 2022 and is estimated to reach $259 Mn in 2030, exhibiting a CAGR of 10.1% during the forecast period. One of the main factors propelling the market's growth is the rising demand for Alzheimer's treatment pharmaceuticals as a result of the increasing prevalence of Alzheimer's disease among the aging population. Leading pharmaceutical companies that are currently working in the market are Pfizer, Biogen, Janssen, Eisai, Novartis, Roche, Lundbeck, Otsuka Pharmaceutical, Teva Pharmaceutical and Sun Pharmaceutical.
South Africa Infectious Disease Drugs Market Analysis
South Africa Infectious Disease Drugs Market valued at $0.77 Bn in 2023, projected to reach $1.12 Bn by 2030 with a 5.50% CAGR. The market is expanding due to factors such as high disease burden, government initiatives, and international partnerships and investments. The market is dominated by key players like Aspen Pharmacare, GlaxoSmithKline plc, Johnson & Johnson, Abbott Laboratories, Merck & Co., Mylan N.V., Cipla Limited, Roche Diagnostics, Sanofi, and Pfizer.
Kenya Infectious Disease Drugs Market Analysis
Kenya Infectious Disease Drugs Market valued at $83.12 Mn in 2023, projected to reach $119.88 Mn by 2030 with a 5.37% CAGR. The market is expanding due to government initiatives, rising awareness and education, and the prevalence of infectious diseases. The market is dominated by key players like Novartis, GlaxoSmithKline plc, AbbVie Inc., Merck & Co., F. Hoffman-La Roche Ltd., Abbott Laboratories, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Pfizer, and Sanofi.
Egypt Infectious Disease Drugs Market Analysis
Egypt Infectious Disease Drugs Market valued at $0.33 Bn in 2023, projected to reach $0.49 Bn by 2030 with a 5.77% CAGR. The market is expanding due to factors like aging populations, rising levels of awareness and education, and emerging infectious diseases. The market is dominated by key players like EIPICO, Pharco Pharmaceuticals, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Vietnam Infectious Disease Drugs Market Analysis
Vietnam Infectious Disease Drugs Market valued at $0.59 Bn in 2023, projected to reach $0.81 Bn by 2030 with a 4.5% CAGR. The industry is influenced by factors such as government healthcare programs, rising infectious disease prevalence, and technological improvements. The market is dominated by key players like Mekophar, Hau Giang Pharmaceutical, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Singapore Infectious Disease Drugs Market Analysis
Singapore Infectious Disease Drugs Market valued at $0.14 Bn in 2023, projected to reach $0.20 Bn by 2030 with a 4.87% CAGR. The market is growing due to the rising prevalence of infectious diseases, the emphasis on research and development, and the adoption of antiviral therapies. The market is dominated by key players like Temasek Life Sciences Laboratory, Acumen Research Laboratories, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Philippines Infectious Disease Drugs Market Analysis
Philippines Infectious Disease Drugs Market valued at $0.26 Bn in 2023, projected to reach $0.36 Bn by 2030 with a 4.77% CAGR. The market is expanding due to the prevalence of infectious diseases, government initiatives and policies, and R&D. The market is dominated by key players like United Laboratories (Unilab), Glovax Biotech Corporation, Pharex Health Corporation, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Japan Infectious Disease Drugs Market Analysis
Japan Infectious Disease Drugs Market valued at $7.38 Bn in 2023, projected to reach $10.23 Bn by 2030 with a 4.77% CAGR. Rising healthcare expenditure, government initiatives and funding, and technological advancements in drug development are driving the market. The market is dominated by key players like Takeda Pharmaceuticals, Daiichi Sankyo, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
UK Infectious Disease Drugs Market Analysis
UK Infectious Disease Drugs Market valued at $3.08 Bn in 2023, projected to reach $3.61 Bn by 2030 with a 2.27% CAGR. Rising antimicrobial resistance, technological advancements, government initiatives, and funding are some of the factors driving the market. The market is dominated by key players like GlaxoSmithKline plc, AstraZeneca, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, and Sanofi S.A.
Spain Infectious Disease Drugs Market Analysis
Spain Infectious Disease Drugs Market valued at $2.29 Bn in 2023, projected to reach $2.87 Bn by 2030 with a 3.27% CAGR. The market is growing due to factors such as the aging population, rising infectious disease prevalence, urbanization, and globalization. The market is dominated by key players like Grifols, AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, and Sanofi S.A.
Germany Infectious Disease Drugs Market Analysis
Germany Infectious Disease Drugs Market valued at $4.34 Bn in 2023, projected to reach $5.16 Bn by 2030 with a 2.47% CAGR. The market is expanding as a result of rising healthcare costs, technological advancements, and an increase in the prevalence of infectious diseases. The market is dominated by key players like BioNTech, AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, and Sanofi S.A.
France Infectious Disease Drugs Market Analysis
France Infectious Disease Drugs Market valued at $3.26 Bn in 2023, projected to reach $4.09 Bn by 2030 with a 3.27% CAGR. The market is driven by partnerships and collaborative research, awareness and education, and the aging population. The market is dominated by key players like Institut Merieux, AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, and Sanofi S.A.
Mexico Infectious Disease Drugs Market Analysis
Mexico Infectious Disease Drugs Market valued at $1.78 Bn in 2023, projected to reach $2.43 Bn by 2030 with a 4.52% CAGR. The market is being driven by advancements in healthcare infrastructure, government initiatives, and rising awareness about infectious diseases. The market is dominated by key players like AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, Sanofi S.A., Bayer AG, and Astellas Pharma Inc.
Brazil Infectious Disease Drugs Market Analysis
Brazil Infectious Disease Drugs Market valued at $2.96 Bn in 2023, projected to reach $4.25 Bn by 2030 with a 5.27% CAGR. The market is expanding due to increased healthcare spending, technological advancements, and awareness and education initiatives. The market is dominated by key players like Hypera Pharma, EMS S.A., AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
UAE Infectious Disease Drugs Market Analysis
UAE Infectious Disease Drugs Market valued at $0.59 Bn in 2023, projected to reach $0.85 Bn by 2030 with a 5.27% CAGR. The market is being driven by the prevalence of infectious diseases, government initiatives, and rising healthcare expenditure. The market is dominated by key players like Hikma Pharmaceuticals, Julphar Gulf Pharmaceutical Industries, Neopharma, AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, and Janssen Pharmaceuticals.
Saudi Arabia Infectious Disease Drugs Market Analysis
Saudi Arabia Infectious Disease Drugs Market valued at $2.02 Bn in 2023, projected to reach $2.99 Bn by 2030 with a 5.77% CAGR. The industry is growing as a result of government initiatives, improvements in healthcare infrastructure, and rising healthcare costs. The market is dominated by key players like SPIMACO, Tabuk Pharmaceuticals, AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Canada Infectious Disease Drugs Market Analysis
Canada Infectious Disease Drugs Market valued at $9.5 Bn in 2023, projected to reach $12.73 Bn by 2030 with a 4.27% CAGR. The market is driven by factors such as rising rates of infectious diseases, technological developments in medication development, and expanding healthcare infrastructure and awareness. The market is dominated by key players like Gilead Sciences, AbbVie Inc., GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, Pfizer Inc., and Sanofi.
US Infectious Disease Drugs Market Analysis
US Infectious Disease Drugs Market valued at $49.87 Bn in 2023, projected to reach $58.36 Bn by 2030 with a 2.27% CAGR. The market is expanding due to the prevalence of infectious diseases, improvements in drug development, and an aging population. The market is dominated by key players like AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, Pfizer Inc., and Lupin Pharmaceuticals.
Vietnam Atopic Dermatitis Therapeutics Market Analysis
The Vietnam Atopic Dermatitis Therapeutics Market was valued at US $62 Mn in 2022, and is predicted to grow at (CAGR) of 9.03% from 2023 to 2030, to US $123 Mn by 2030. The key drivers of this industry include the increased burden of Atopic Dermatitis (AD), improving healthcare infrastructure, shifting patient preferences, and others. The industry is primarily dominated by players such as Sanofi, Pharmacity, Merck, AbbVie, Domesco, Novartis, and Johnson & Johnson, among others.
